- Investing Ideas
- /
- Global Small Cap High Growth Stocks
Global Small Cap High Growth Stocks
UPDATED Jul 05, 2022
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
4,977 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GMTXGemini Therapeutics | US$1.63 | -3.0% | -71.6% | US$70.5m | US$1.88 | PB0.6x | E18.6% | n/a | Pharmaceuticals & Biotech | ||
| IMRAIMARA | US$1.16 | -4.1% | -84.7% | US$30.5m | US$1.20 | PB0.4x | E29.1% | n/a | Pharmaceuticals & Biotech | ||
| RPHMReneo Pharmaceuticals | US$2.91 | 30.5% | -68.8% | US$71.2m | US$24.60 | PB0.5x | E19.6% | n/a | Pharmaceuticals & Biotech | ||
| ANNXAnnexon | US$3.75 | -6.3% | -83.7% | US$144.6m | US$26.25 | PB0.7x | E1.2% | n/a | Pharmaceuticals & Biotech | ||
| BNXABanxa Holdings | CA$1.12 | -13.2% | -73.0% | CA$51.0m | CA$3.90 | PB3.7x | E59.0% | n/a | Software | ||
| AKUSAkouos | US$3.46 | -29.2% | -72.4% | US$119.8m | US$20.50 | PB0.6x | E27.2% | n/a | Pharmaceuticals & Biotech | ||
| ALNAAllena Pharmaceuticals | US$0.19 | 62.5% | -84.8% | US$22.2m | n/a | PB1.9x | E25.7% | n/a | Pharmaceuticals & Biotech | ||
| AKBAAkebia Therapeutics | US$0.41 | 16.8% | -88.3% | US$75.1m | US$1.63 | PB2.9x | E25.8% | n/a | Pharmaceuticals & Biotech | ||
| MISTMilestone Pharmaceuticals | US$6.07 | -1.0% | 8.4% | US$181.6m | US$14.40 | PS12.1x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
| RVGRevival Gold | CA$0.50 | -9.1% | -26.5% | CA$43.4m | CA$1.59 | PB2.7x | E33.8% | n/a | Materials | ||
| BLCMBellicum Pharmaceuticals | US$1.38 | 14.1% | -56.9% | US$11.9m | US$5.00 | PS1.9x | E1.8% | n/a | Pharmaceuticals & Biotech | ||
| ABUSArbutus Biopharma | US$2.88 | 10.3% | -1.7% | US$428.3m | US$6.43 | PS20x | E9.1% | n/a | Pharmaceuticals & Biotech | ||
| XELAExela Technologies | US$0.11 | -16.1% | -95.8% | US$49.2m | US$1.18 | PE-0.3x | E27.9% | n/a | Software | ||
| SCORcomScore | US$1.99 | -2.0% | -58.0% | US$180.5m | US$3.25 | PB0.8x | E23.2% | n/a | Media | ||
| NCNANuCana | US$0.67 | -14.9% | -75.1% | US$34.8m | US$4.69 | PB0.5x | E50.6% | n/a | Pharmaceuticals & Biotech | ||
| KTRAKintara Therapeutics | US$0.25 | -11.9% | -87.1% | US$16.3m | US$3.25 | PE-0.6x | E41.3% | n/a | Pharmaceuticals & Biotech | ||
| LBSLBS Bina Group Berhad | RM0.42 | 0% | -8.7% | RM655.0m | n/a | PB0.5x | E1.5% | 4.8% | Real Estate | ||
| MKM.K. Real Estate Development | ฿2.94 | -1.3% | -6.4% | ฿3.2b | ฿3.12 | PB0.5x | E40.7% | 0% | Real Estate | ||
| 532259Apar Industries | ₹940.25 | 0.2% | 73.0% | ₹36.0b | ₹829.00 | PE14x | E4.0% | 1.6% | Capital Goods | ||
| LIANLianBio | US$2.43 | 10.5% | n/a | US$263.1m | US$15.78 | PB0.8x | E36.6% | n/a | Pharmaceuticals & Biotech | ||
| SVMSovereign Metals | AU$0.47 | 0% | -25.6% | AU$218.9m | AU$1.35 | PB21x | E58.8% | n/a | Materials | ||
| KIPREITKIP Real Estate Investment Trust | RM0.89 | 0% | 5.3% | RM449.7m | n/a | PB0.9x | E3.3% | 7.7% | Real Estate | ||
| DRCDanang Rubber | â‚«26,300.00 | -4.2% | -9.3% | â‚«3.1t | â‚«36,633.33 | PE10.7x | E3.2% | 6.5% | Automobiles | ||
| CBYCanterbury Resources | AU$0.047 | 9.3% | -53.0% | AU$5.8m | n/a | PB0.5x | E58.6% | n/a | Materials |